Tenax Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TENX)

Financials

Cash from operating activities -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M Cash from investing activities 00000 0 Cash from financing activities 92.01 M67 K23.56 M278 K3.06 M 26.97 M Free cash flow -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M

新闻

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

Tenax Therapeutics公司的第三期LEVEL研究确认招募目标

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

古根海姆将Tenax Therapeutics目标价从14美元上调至25美元

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

Tenax Therapeutics董事Rich Stuart购入价值$50,792的股票

Tenax Therapeutics director Rich Stuart buys $50,792 in stock

Giordano buys Tenax Therapeutics (TENX) shares worth $19,999

Tenax Therapeutics临时CFO McGauley购入价值58,164美元股票